RIZATRIPTAN Drug Patent Profile

Which patents cover Rizatriptan, and what generic alternatives are available?

Rizatriptan is a drug marketed by Apotex Inc, Aurobindo Pharma Ltd, Chartwell Rx, Glenmark Pharms Ltd, Jubilant Generics, Macleods Pharms Ltd, Natco Pharma Ltd, Panacea, Pharmobedient, Unichem, Alkem Labs Ltd, Avet Lifesciences, Creekwood Pharms, Invagen Pharms, Sandoz, and Teva Pharms. and is included in twenty-five NDAs.

The generic ingredient in RIZATRIPTAN is rizatriptan benzoate. There are twenty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the rizatriptan benzoate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Rizatriptan

A generic version of RIZATRIPTAN was approved as rizatriptan benzoate by AUROBINDO PHARMA LTD on December 31^st, 2012.

Summary for RIZATRIPTAN

US Patents:	0
Applicants:	16
NDAs:	25
Drug Prices:	Drug price information for RIZATRIPTAN
Drug Sales Revenues:	Drug sales revenues for RIZATRIPTAN
DailyMed Link:	RIZATRIPTAN at DailyMed

See drug prices for RIZATRIPTAN

See drug sales revenues for RIZATRIPTAN

US Patents and Regulatory Information for RIZATRIPTAN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Natco Pharma Ltd	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET;ORAL	200482-001	Dec 31, 2012		DISCN	No	No
Creekwood Pharms	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET;ORAL	202047-002	Dec 31, 2012	AB	RX	No	No
Unichem	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET;ORAL	207836-001	Mar 7, 2017		DISCN	No	No
Sandoz	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET;ORAL	079230-001	Dec 31, 2012		DISCN	No	No
Unichem	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET;ORAL	207836-002	Mar 7, 2017		DISCN	No	No
Avet Lifesciences	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET;ORAL	204090-002	Nov 26, 2013		DISCN	No	No
Glenmark Pharms Ltd	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET;ORAL	201967-001	Dec 31, 2012		DISCN	No	No